PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2026)
PROCEPT BioRobotics (PRCT) posted quarterly Total Current Liabilities of $63.6 million for Q1 2026, up 22.23% year-over-year from $52.1 million in Q1 2025, and down 3.28% quarter-over-quarter from $65.8 million in Q4 2025.
PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Total Current Liabilities for 7 consecutive years, with $63.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 22.23% year-over-year to $63.6 million; the TTM figure through Mar 2026 stood at $63.6 million (up 22.23% YoY), while the FY2025 annual figure was $65.8 million, up 23.83% from the prior year.
- Total Current Liabilities retreated to $63.6 million in Q1 2026 per PRCT's latest filing, from $65.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $65.8 million in Q4 2025 and bottomed at $14.8 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $42.7 million across 5 years, with a median of $42.8 million in 2024.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 120.26% — and 2025, when it advanced 0.47%.
- PROCEPT BioRobotics' Total Current Liabilities stood at $35.3 million in 2022, then surged by 30.14% to $45.9 million in 2023, then climbed by 15.69% to $53.1 million in 2024, then rose by 23.83% to $65.8 million in 2025, then retreated by 3.28% to $63.6 million in 2026.
- Business Quant data shows PRCT's Total Current Liabilities at $63.6 million in Q1 2026, $65.8 million in Q4 2025, and $53.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | PROCEPT BioRobotics | 1.19 Bn | 911.91 Mn | 62.38 Mn | 64.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.20 Mn |
| Mar 31, 2026 | 63.64 Mn |
| Dec 31, 2025 | 65.80 Mn |
| Sep 30, 2025 | 53.90 Mn |
| Jun 30, 2025 | 49.73 Mn |
| Mar 31, 2025 | 52.06 Mn |
| Dec 31, 2024 | 53.13 Mn |
| Sep 30, 2024 | 53.65 Mn |
| Jun 30, 2024 | 42.85 Mn |
| Mar 31, 2024 | 38.65 Mn |
| Dec 31, 2023 | 45.93 Mn |
| Sep 30, 2023 | 41.36 Mn |
| Jun 30, 2023 | 35.95 Mn |
| Mar 31, 2023 | 32.50 Mn |
| Dec 31, 2022 | 35.29 Mn |
| Sep 30, 2022 | 27.36 Mn |
| Jun 30, 2022 | 18.63 Mn |
| Mar 31, 2022 | 14.76 Mn |
| Dec 31, 2021 | 16.24 Mn |
| Sep 30, 2021 | 14.18 Mn |